Ulcerative colitis: open trials in Puerto Rico

4 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
CMRC Headlands, LLC, San Juan
Registry updated 2026-11-04
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Pan American Center for Oncology Trials - Ciudadela, San Juan · Adult University Hospital, San Juan
Registry updated 2026-11-04
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Puerto Rico Health and Wellness Institute-Site Number: 8400104, Dorado · Wellness Clinical Research - Vega Baja-Site Number: 8400099, Vega Baja
Registry updated 2026-10-23
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Clinical Research Puerto Rico, San Juan
Registry updated 2026-10-20

This page is not medical advice. Talk to your doctor before contacting a trial.

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study